AVERSA, FABIOLA
 Distribuzione geografica
Continente #
NA - Nord America 213
AS - Asia 97
EU - Europa 34
SA - Sud America 2
Totale 346
Nazione #
US - Stati Uniti d'America 202
CN - Cina 34
SG - Singapore 34
BG - Bulgaria 13
SE - Svezia 12
CA - Canada 10
HK - Hong Kong 8
TR - Turchia 8
VN - Vietnam 8
FR - Francia 4
IN - India 3
RU - Federazione Russa 3
ID - Indonesia 2
CO - Colombia 1
DE - Germania 1
GB - Regno Unito 1
MX - Messico 1
PY - Paraguay 1
Totale 346
Città #
Fairfield 28
Ashburn 23
Chandler 20
Singapore 19
Seattle 13
Sofia 13
Woodbridge 13
Wilmington 11
Beijing 10
San Jose 10
Des Moines 9
Hong Kong 8
Houston 8
New York 8
Ottawa 8
Shanghai 8
Izmir 6
Cambridge 5
Boardman 4
Columbus 4
Lauterbourg 4
Lawrence 4
Nanjing 4
Princeton 4
The Dalles 4
Ann Arbor 3
Council Bluffs 3
Dallas 3
Medford 3
Pune 3
Buffalo 2
Dearborn 2
Ho Chi Minh City 2
Redondo Beach 2
Bogor 1
Brooklyn 1
Bắc Ninh 1
Chongqing 1
Da Nang 1
Dong Ket 1
Durango 1
Erzurum 1
Grafing 1
Hanoi 1
Hefei 1
Istanbul 1
Jakarta 1
Kunming 1
London 1
Luque 1
Medellín 1
Nanchang 1
Ningbo 1
San Francisco 1
Scarborough 1
Shenyang 1
St. John's 1
Wenzhou 1
Wuhan 1
Zhengzhou 1
Totale 297
Nome #
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients 102
Teicoplanin in empirical combined antibiotic therapy of bacteraemias in bone marrow transplant patients 94
Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole 92
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation 62
Totale 350
Categoria #
all - tutte 1.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/202248 2 0 4 0 13 9 0 1 1 5 1 12
2022/202333 5 4 0 4 7 8 0 2 2 1 0 0
2023/202420 1 3 0 0 4 9 0 0 0 0 0 3
2024/202561 0 6 0 5 3 3 8 8 4 13 7 4
2025/202661 4 6 4 3 6 10 19 2 3 4 0 0
Totale 350